Patents Assigned to Abbott Labortories
  • Patent number: 7320986
    Abstract: Compounds having the formula (I) are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
    Type: Grant
    Filed: March 3, 2004
    Date of Patent: January 22, 2008
    Assignee: Abbott Labortories
    Inventors: Yunsong Tong, Akiyo K. Claiborne, Gaoquan Li, Nan-Horng Lin, Hing L. Sham, Thomas J. Sowin, Zhi-Fu Tao
  • Patent number: 7208517
    Abstract: A compound of the formula (I): or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, a method of antagonizing endothelin, methods for the inhibition of bone metastases, methods for the prevention of growth of new metastases, methods for the inhibition of bone turnover, and methods for the prevention of bone loss in patients, including cancer patients, using an endothelin ET-A receptor antagonist.
    Type: Grant
    Filed: August 31, 2000
    Date of Patent: April 24, 2007
    Assignee: Abbott Labortories
    Inventors: Martin Winn, Steven A. Boyd, Charles W. Hutchins, Hwan-Soo Jae, Andrew S. Tasker, Thomas W. von Geldern, Jeffrey A. Kester, Bryan K. Sorensen, Bruce G. Szczepankiewicz, Kenneth J. Henry, Gang Liu, Steven J. Wittenberger, Steven A. King, Todd J. Janus, Robert J. Padley
  • Publication number: 20050004655
    Abstract: Abstract of the Disclosure The present invention provides a stent comprising a tubular flexible body having a wall with a web structure that is expandable from a contracted delivery configuration to deployed configuration. The web structure comprises a plurality of neighboring web patterns, where each web patterns is composed of adjoining webs, and the web patterns are interconnected. Each adjoining web comprises a central section interposed between two lateral sections to form concave or convex configurations.
    Type: Application
    Filed: December 22, 2003
    Publication date: January 6, 2005
    Applicant: Abbott Labortories Vascular Enterprises Limited
    Inventors: Randolf Von Oepen, Gerd Seibold
  • Patent number: 6635491
    Abstract: A method for determining the concentration of an analyte in tissues. The method involves compensating for a change in the value of an optical property of the tissues, such as, for example, the scattering coefficient, resulting from a change in the hydration status of the tissues.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: October 21, 2003
    Assignee: Abbott Labortories
    Inventors: Omar S. Khalil, Johannes Sake Kanger, Reneā€² Alexander Bolt, Frits Frans Maria de Mul
  • Patent number: 6403641
    Abstract: A method for the treatment of obesity in a human in need of such treatment which comprises administration to the human of a therapeutically effective amount of a compound of formula I including enantiomers and pharmaceutically acceptable salts thereof, in which R1 and R2 are independently H or methyl, and a therapeutically effective amount of a compound of formula II wherein the compound of formula I and the compound of formula II are administered simultaneously, separately or sequentially.
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: June 11, 2002
    Assignee: Abbott Labortories
    Inventors: David John Heal, Helen Christine Jackson
  • Patent number: 5892052
    Abstract: A retroviral protease inhibiting compound of the formula: ##STR1## is disclosed.
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: April 6, 1999
    Assignee: Abbott Labortories
    Inventors: Dale J. Kempf, Daniel W. Norbeck, Hing Leung Sham, Chen Zhao